Objectives: We investigated clinical correlates of atrial fibrillation (AF) progression and evaluated the prognosis of patients demonstrating AF progression in a large population. Background: Progression of paroxysmal AF to more sustained forms is frequently seen. However, not all patients will progress to persistent AF. Methods: We included 1,219 patients with paroxysmal AF who participated in the Euro Heart Survey on AF and had a known rhythm status at follow-up. Patients who experienced AF progression after 1 year of follow-up were identified. Results: Progression of AF occurred in 178 (15%) patients. Multivariate analysis showed that heart failure, age, previous transient ischemic attack or stroke, chronic obstructive pulmonary disease, and hypertension were the only independent predictors of AF progression. Using the regression coefficient as a benchmark, we calculated the HATCH score. Nearly 50% of the patients with a HATCH score >5 progressed to persistent AF compared with only 6% of the patients with a HATCH score of 0. During follow-up, patients with AF progression were more often admitted to the hospital and had more major adverse cardiovascular events. Conclusions: A substantial number of patients progress to sustained AF within 1 year. The clinical outcome of these patients regarding hospital admissions and major adverse cardiovascular events was worse compared with patients demonstrating no AF progression. Factors known to cause atrial structural remodeling (age and underlying heart disease) were independent predictors of AF progression. The HATCH score may help to identify patients who are likely to progress to sustained forms of AF in the near future. © 2010 American College of Cardiology Foundation.

Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis / de Vos C.B.; Pisters R.; Nieuwlaat R.; Prins M.H.; Tieleman R.G.; Coelen R.-J.S.; van den Heijkant A.C.; Allessie M.A.; Crijns H.J.G.M.; Andresen D.; Camm A.J.; Davies W.; Capucci A.; Levy S.; Olsson B.; Aliot E.; Breithardt G.; Cobbe S.; Le Heuzey J.-Y.; Santini M.; Vardas P.; Manini M.; Bramley C.; Laforest V.; Taylor C.; Del Gaiso S.; Huber K.; De Backer G.; Sirakova V.; Cerbak R.; Thayssen P.; Lehto S.; Blanc J.-J.; Delahaye F.; Kobulia B.; Zeymer U.; Cokkinos D.; Karlocai K.; Graham I.; Shelley E.; Behar S.; Maggioni A.; Goncalves L.; Grabauskiene V.; Asmussen I.; Deckers J.; Stepinska J.; Mareev V.; Vasiljevic Z.; Riecansky I.; Kenda M.F.; Alonso A.; Lopez-Sendon J.L.; Rosengren A.; Buser P.; Okay T.; Sychov O.; Fox K.; Schofield P.; Simoons M.; Wood D.; Battler A.; Boersma E.; Fox K.; Komajda M.; McGregor K.; Mulder B.; Priori S.; Ryden L.; Vahanian A.; Wijns W.; Sanofi-Aventis; Grigoryan S.V.; Apetyan I.; Aroyan S.; Azarapetyan L.; Anvari A.; Gottsauner-Wolf M.; Pfaffenberger S.; Aydinkoc K.; Kalla K.; Penka M.; Drexel H.; Langer P.; Pierard L.A.; Legrand V.; Blommaert D.; Schroeder E.; Mancini I.; Geelen P.; Brugada P.; De Zutter M.; Vrints C.; Vercammen M.; Morissens M.; Borisov B.; Petrov V.A.; Marinova M.; Assen A.; Goudev R.; Peychev Y.; Stoyanovsky V.; Stoynev E.; Kranjcevic S.; Moutiris J.; Ioannides M.; Evequoz D.; Spacilova J.; Novak M.; Eisenberger M.; Mullerova J.; Kautzner J.; Riedlbauchova L.; Petru` J.; Taborsky M.; Cappelen H.; Sharaf Y.A.; Ibrahim B.S.S.; Tammam K.; Saad A.; Elghawaby H.; Sherif H.Z.; Farouk H.; Mielke A.; Engelen M.; Kirchhof P.; Zimmermann P.; Aviles F.F.; Rubio J.; Malpartida F.; Corona M.; Sanchez L.T.; Miguel J.; Herrera L.; Quesada A.; Garcia A.J.M.; Gonzalez C.S.; Juango M.S.A.; Berjon-Reyero J.; Alegret J.M.; Fernandez J.M.C.; Carrascosa C.; Romero R.A.F.; Lara M.G.; Sendon J.L.L.; de Diego J.J.G.; Martin L.S.; Irurita M.; Guttierez N.H.; Rubio J.R.S.; Antorrena I.; Paves A.B.; Salvador A.; Orriach M.D.; Garcia A.A.; Epelde F.; Martinez V.B.; Sanchez A.B.; Galvez C.P.; Rivero R.F.; Madrid A.H.; Baron-Esquivias G.; Peinado R.; Guindal J.A.G.; Vera T.R.; Fernandez E.L.; Gayan R.; Garcia J.; Bodegas A.; Lopez J.T.; Florez J.M.; Cabezas C.L.; de Castroviejo E.V.R.; Bellido J.M.; Ruiz M.E.; Savolainen K.; Nieminen M.; Toivonen L.; Syvanne M.; Pietila M.; Galley D.; Beltra C.; Gay A.; Daubert J.C.; Lecocq G.; Poulain C.; Cleland J.G.F.C.; Shelton R.; Choudhury A.; Abuladze G.; Jashi I.; Tsiavou A.; Giamouzis G.; Dagres N.; Kostopoulou A.; Tsoutsanis D.; Stefanadis C.; Latsios G.; Vogiatzis I.; Gotsis A.; Bozia P.; Karakiriou M.; Koulouris S.; Parissis J.; Kostakis G.; Kouris N.; Kontogianni D.; Athanasios K.; Douras A.; Tsanakis T.; Marketou M.; Patsourakos N.; Czopf L.; Halmosi R.; Preda I.; Csoti E.; Badics A.; Strasberg B.; Freedberg N.A.; Katz A.; Zalzstein E.; Grosbard A.; Goldhammer E.; Nahir M.; Epstein M.; Vider I.; Luria D.; Mandelzweig L.; Aloisi B.; Cavallaro A.; Antonielli E.; Doronzo B.; Pancaldo D.; Mazzola C.; Buontempi L.; Calvi V.; Giuffrida G.; Figlia A.; Ippolito F.; Gelmini G.-P.; Gaibazzi N.; Ziacchi V.; De Tommasi F.; Lombardi F.; Fiorentini C.; Terranova P.; Maiolino P.; Albunni M.; Pinna-Pintor P.; Fumagalli S.; Masotti G.; Boncinelli L.; Rossi D.; Santoro G.M.; Fioranelli M.; Naccarella F.; Maranga S.S.; Lepera G.; Bresciani B.; Seragnoli E.; Forti M.C.; Cortina V.; Baciarello G.; Cicconetti P.; Lax A.; Vitali F.; Igidbashian D.; Scarpino L.; Terrazzino S.; Tavazzi L.; Cantu F.; Pentimalli F.; Novo S.; Coppola G.; Zingarini G.; Ambrozio G.; Moruzzi P.; Callegari S.; Saccomanno G.; Russo P.; Carbonieri E.; Paino A.; Zanetta M.; Barducci E.; Cemin R.; Rauhe W.; Pitscheider W.; Meloni M.; Marchi S.M.; Di Gennaro M.; Calcagno S.; Squaratti P.; Quartili F.; Bertocchi P.; De Martini M.; Mantovani G.; Komorovsky R.; Desideri A.; Celegon L.; Tarantini L.; Catania G.; Lucci D.; Bianchini F.; Puodziukynas A.; Kavoliuniene A.; Barauskiene V.; Aidietis A.; Barysiene J.; Vysniauskas V.; Zukauskiene I.; Kazakeviciene N.; Georgievska-Ismail L.; Poposka L.; Vataman E.; Grosu A.A.; op Reimer W.S.; de Swart E.; Lenzen M.; Jansen C.; Brons R.; Tebbe H.; van Hoogenhuyze D.C.A.; Veerhoek M.J.; Kamps M.; Haan D.; van Rijn N.; Bootsma A.; Baur L.; van den A.; Fransen H.; Eurlings L.; Meeder J.; De Boer M.J.; Winter J.; Broers H.; Werter C.; Bijl M.; Versluis S.; Milkowska M.; Wozakowska-Kaplon B.; Janion M.; Lepska L.; Swiatecka G.; Kokowicz P.; Cybulski J.; Gorecki A.; Szulc M.; Rekosz J.; Manczak R.; Wnuk-Wojnar A.-M.; Trusz-Gluza M.; Rybicka-Musialik A.; Myszor J.; Szpajer M.; Cymerman K.; Sadowski J.; Sniezek-Maciejewska M.; Ciesla-Dul M.; Gorkiewicz-Kot I.; Grodzicki T.; Rewiuk K.; Kubik L.; Lewit J.; de Sousa J.M.F.R.; Ferreira R.; Freitas A.; Morais J.C.A.; Pires R.; Gomes M.J.V.; Gago P.; Candeias R.A.C.; Nunes L.; Sa J.V.M.; Ventura M.; de Oliveira M.; Alves L.B.; Bostaca I.; Olariu C.T.; Dan G.A.; Dan A.; Podoleanu C.; Frigy A.; Georgescu G.I.M.; Arsenescu C.; Statescu C.; Sascau R.; Dimitrascu D.L.; Rancea R.; Shubik Y.V.; Duplyakov D.; Shalak M.; Danielyan M.; Galyavich A.; Zakirova V.; Hatala R.; Kaliska G.; Kmec J.; Zupan I.; Tasie` J.; Vokac D.; Edvardsson N.; Poci D.; Gamra H.; Denguir H.; Sepetoglu A.; Arat-Ozkan A.; Orynchak M.; Paliy E.; Vakalyuk I.; Malidze D.; Prog R.; Yabluchansky M.I.; Makienko N.V.; Potpara T.; Knezevic S.; Randjelovic M.. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - ELETTRONICO. - 55:(2010), pp. 725-731. [10.1016/j.jacc.2009.11.040]

Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis

Fumagalli S.;Masotti G.;Boncinelli L.;
2010

Abstract

Objectives: We investigated clinical correlates of atrial fibrillation (AF) progression and evaluated the prognosis of patients demonstrating AF progression in a large population. Background: Progression of paroxysmal AF to more sustained forms is frequently seen. However, not all patients will progress to persistent AF. Methods: We included 1,219 patients with paroxysmal AF who participated in the Euro Heart Survey on AF and had a known rhythm status at follow-up. Patients who experienced AF progression after 1 year of follow-up were identified. Results: Progression of AF occurred in 178 (15%) patients. Multivariate analysis showed that heart failure, age, previous transient ischemic attack or stroke, chronic obstructive pulmonary disease, and hypertension were the only independent predictors of AF progression. Using the regression coefficient as a benchmark, we calculated the HATCH score. Nearly 50% of the patients with a HATCH score >5 progressed to persistent AF compared with only 6% of the patients with a HATCH score of 0. During follow-up, patients with AF progression were more often admitted to the hospital and had more major adverse cardiovascular events. Conclusions: A substantial number of patients progress to sustained AF within 1 year. The clinical outcome of these patients regarding hospital admissions and major adverse cardiovascular events was worse compared with patients demonstrating no AF progression. Factors known to cause atrial structural remodeling (age and underlying heart disease) were independent predictors of AF progression. The HATCH score may help to identify patients who are likely to progress to sustained forms of AF in the near future. © 2010 American College of Cardiology Foundation.
2010
55
725
731
Goal 3: Good health and well-being for people
de Vos C.B.; Pisters R.; Nieuwlaat R.; Prins M.H.; Tieleman R.G.; Coelen R.-J.S.; van den Heijkant A.C.; Allessie M.A.; Crijns H.J.G.M.; Andresen D.; ...espandi
File in questo prodotto:
File Dimensione Formato  
ParoxPersistentAF_JACC_2010.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 197.18 kB
Formato Adobe PDF
197.18 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1206499
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 543
  • ???jsp.display-item.citation.isi??? 499
social impact